Jan 2022 Articles

Articles
Homozygous Familial Hypercholesterolaemia International Clinical Collaborators. Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study
Tromp TR, Hartgers ML, Hovingh GK, et al.
Journal:
Lancet

First published: January 28, 2022 DOI: 10.1016/S0140-6736(21)02001-8
View
- Share
Articles
Socioeconomic Disparities in Healthcare Utilization for Atherosclerotic Cardiovascular Disease
Jain B, Bajaj SS, Paguio JA, et al.
Journal:
Am Heart J

First published: January 27, 2022 DOI: 10.1016/j.ahj.2022.01.011
View
- Share
Articles
Association of Lipoprotein(a) With Atherosclerotic Plaque Progression
Kaiser Y, Daghem M, Tzolos E, et al.
Journal:
J Am Coll Cardiol.

First published: January 25, 2022 DOI: 10.1016/j.jacc.2021.10.044
View
- Share
Articles
An evaluation of the pharmacokinetics of inclisiran in the treatment of atherosclerotic cardiovascular disease
Tomlinson B, Chow E, Chan P, et al.
Journal:
Expert Opin Drug Metab Toxicol

First published: January 20, 2022 DOI: 10.1080/17425255.2021.2029402
View
- Share
Articles
The dawn of a new era of targeted lipid-lowering therapies
Tokgözoğlu L, Libby P
Journal:
Eur Heart J

First published: January 20, 2022 DOI: 10.1093/eurheartj/ehab841
View
- Share
Articles
Consistency of Benefit of Icosapent Ethyl by Background Statin Type in REDUCE-IT
Singh N, Bhatt DL, Miller M, et al.
Journal:
J Am Coll Cardiol

First published: January 18, 2022 DOI: 10.1016/j.jacc.2021.11.005
View
- Share
Articles
The waist-to-body mass index ratio as an anthropometric predictor for cardiovascular outcome in subjects with established atherosclerotic cardiovascular disease
Hsuan CF, Lin FJ, Lee TL, et al.
Journal:
Sci Rep

First published: January 17, 2022 DOI: 10.1038/s41598-021-04650-5
View
- Share
Articles
How Can We Identify Very High-Risk Heterozygous Familial Hypercholesterolemia?
Kataoka Y, Funabashi S, Doi T, et al.
Journal:
J Atheroscler Thromb

First published: January 13, 2022 DOI: 10.5551/jat.RV17063
View
- Share
Articles
Association between Achilles Tendon Softness and Atherosclerotic Cardiovascular Disease in Patients with Familial Hypercholesterolemia
Michikura M, Ogura M, Hori M, et al.
Journal:
J Atheroscler Thromb

First published: January 9, 2022 DOI: 10.5551/jat.63151
View
- Share
Articles
Associations Among PCSK9 Levels, Atherosclerosis-Derived Extracellular Vesicles, and Their miRNA Content in Adults With Obesity
Macchi C, Greco MF, Favero C, et al.
Journal:
Front Cardiovasc Med

First published: January 7, 2022 DOI: 10.3389/fcvm.2021.785250
View
- Share
Articles
Pharmacokinetics and pharmacodynamics of inclisiran, a small interfering RNA therapy, in patients with hepatic impairment
David Kallend, Robert Stoekenbroek, YanLing He, et al.
Journal:
J Clin Lipidol

First published: January 7, 2022 DOI: 10.1016/j.jacl.2022.01.001
View
- Share
Articles
Evaluation of Factors Underlying Sex-Based Disparities in Cardiovascular Care in Adults With Self-reported Premature Atherosclerotic Cardiovascular Disease
Jain V, Al Rifai M, Turpin R, et al.
Journal:
JAMA Cardiol

First published: January 5, 2022 DOI: 10.1001/jamacardio.2021.5430
View
- Share

1 2

Jan 2022 Articles

Articles

Homozygous Familial Hypercholesterolaemia International Clinical Collaborators. Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study

Tromp TR, Hartgers ML, Hovingh GK, et al.

Articles

Socioeconomic Disparities in Healthcare Utilization for Atherosclerotic Cardiovascular Disease

Jain B, Bajaj SS, Paguio JA, et al.

Articles

Association of Lipoprotein(a) With Atherosclerotic Plaque Progression

Kaiser Y, Daghem M, Tzolos E, et al.

Articles

An evaluation of the pharmacokinetics of inclisiran in the treatment of atherosclerotic cardiovascular disease

Tomlinson B, Chow E, Chan P, et al.

Articles

The dawn of a new era of targeted lipid-lowering therapies

Tokgözoğlu L, Libby P

Articles

Consistency of Benefit of Icosapent Ethyl by Background Statin Type in REDUCE-IT

Singh N, Bhatt DL, Miller M, et al.

Articles

The waist-to-body mass index ratio as an anthropometric predictor for cardiovascular outcome in subjects with established atherosclerotic cardiovascular disease

Hsuan CF, Lin FJ, Lee TL, et al.

Articles

How Can We Identify Very High-Risk Heterozygous Familial Hypercholesterolemia?

Kataoka Y, Funabashi S, Doi T, et al.

Articles

Association between Achilles Tendon Softness and Atherosclerotic Cardiovascular Disease in Patients with Familial Hypercholesterolemia

Michikura M, Ogura M, Hori M, et al.

Articles

Associations Among PCSK9 Levels, Atherosclerosis-Derived Extracellular Vesicles, and Their miRNA Content in Adults With Obesity

Macchi C, Greco MF, Favero C, et al.

Articles

Pharmacokinetics and pharmacodynamics of inclisiran, a small interfering RNA therapy, in patients with hepatic impairment

David Kallend, Robert Stoekenbroek, YanLing He, et al.

Articles

Evaluation of Factors Underlying Sex-Based Disparities in Cardiovascular Care in Adults With Self-reported Premature Atherosclerotic Cardiovascular Disease

Jain V, Al Rifai M, Turpin R, et al.

Articles

Homozygous Familial Hypercholesterolaemia International Clinical Collaborators. Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study

Tromp TR, Hartgers ML, Hovingh GK, et al.

Share

Articles

Socioeconomic Disparities in Healthcare Utilization for Atherosclerotic Cardiovascular Disease

Jain B, Bajaj SS, Paguio JA, et al.

Share

Articles

Association of Lipoprotein(a) With Atherosclerotic Plaque Progression

Kaiser Y, Daghem M, Tzolos E, et al.

Share

Articles

An evaluation of the pharmacokinetics of inclisiran in the treatment of atherosclerotic cardiovascular disease

Tomlinson B, Chow E, Chan P, et al.

Share

Articles

The dawn of a new era of targeted lipid-lowering therapies

Tokgözoğlu L, Libby P

Share

Articles

Consistency of Benefit of Icosapent Ethyl by Background Statin Type in REDUCE-IT

Singh N, Bhatt DL, Miller M, et al.

Share

Articles

The waist-to-body mass index ratio as an anthropometric predictor for cardiovascular outcome in subjects with established atherosclerotic cardiovascular disease

Hsuan CF, Lin FJ, Lee TL, et al.

Share

Articles

How Can We Identify Very High-Risk Heterozygous Familial Hypercholesterolemia?

Kataoka Y, Funabashi S, Doi T, et al.

Share

Articles

Association between Achilles Tendon Softness and Atherosclerotic Cardiovascular Disease in Patients with Familial Hypercholesterolemia

Michikura M, Ogura M, Hori M, et al.

Share

Articles

Associations Among PCSK9 Levels, Atherosclerosis-Derived Extracellular Vesicles, and Their miRNA Content in Adults With Obesity

Macchi C, Greco MF, Favero C, et al.

Share

Articles

Pharmacokinetics and pharmacodynamics of inclisiran, a small interfering RNA therapy, in patients with hepatic impairment

David Kallend, Robert Stoekenbroek, YanLing He, et al.

Share

Articles

Evaluation of Factors Underlying Sex-Based Disparities in Cardiovascular Care in Adults With Self-reported Premature Atherosclerotic Cardiovascular Disease

Jain V, Al Rifai M, Turpin R, et al.

Share